Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Behzad Hajarizadeh

Showing results (1-10 of 157) with videos related to

Pageof 16
Sort By:
Infectious Disease Clinics of North America|May 21, 2018
Elimination of Hepatitis C Virus in Australia: Laying the FoundationGregory J Dore, Behzad Hajarizadeh
Australian Family Physician|October 3, 2015
Patients' perspectives on the delivery of hepatitis B management and careJacqueline Richmond, Behzad Hajarizadeh, Jack Wallace
Journal of Hepatology|July 17, 2012
Case definitions for acute hepatitis C virus infection: a systematic reviewBehzad Hajarizadeh, Jason Grebely, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology|August 24, 2017
Direct-acting antiviral agents for HCV infection affecting people who inject drugsJason Grebely, Behzad Hajarizadeh, Gregory J Dore
Australian Prescriber|March 7, 2018
Observations on the launch of new drugs for hepatitis CMarianne Martinello, Behzad Hajarizadeh, Gregory J Dore
Nephrology (Carlton, Vic.)|June 4, 2008
Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patientsShahnaz Sali, Seyed M Alavian, Behzad Hajarizadeh
The Medical Journal of Australia|April 20, 2020
Hepatitis C elimination in Australia: progress and challengesMarianne Martinello, Behzad Hajarizadeh, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology|July 3, 2013
Epidemiology and natural history of HCV infectionBehzad Hajarizadeh, Jason Grebely, Gregory J Dore
Australian and New Zealand Journal of Public Health|October 5, 2013
Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners' perspectiveJack Wallace, Behzad Hajarizadeh, Jacqui Richmond, et al.
BMC Endocrine Disorders|November 24, 2004
Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver diseaseSeyed M Alavian, Behzad Hajarizadeh, Fariborz Nematizadeh, et al.
Pageof 16

Showing results (1-10 of 157) with videos related to

Sort By:
Pageof 16
Infectious Disease Clinics of North America|May 21, 2018
Elimination of Hepatitis C Virus in Australia: Laying the FoundationGregory J Dore, Behzad Hajarizadeh
Australian Family Physician|October 3, 2015
Patients' perspectives on the delivery of hepatitis B management and careJacqueline Richmond, Behzad Hajarizadeh, Jack Wallace
Journal of Hepatology|July 17, 2012
Case definitions for acute hepatitis C virus infection: a systematic reviewBehzad Hajarizadeh, Jason Grebely, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology|August 24, 2017
Direct-acting antiviral agents for HCV infection affecting people who inject drugsJason Grebely, Behzad Hajarizadeh, Gregory J Dore
Australian Prescriber|March 7, 2018
Observations on the launch of new drugs for hepatitis CMarianne Martinello, Behzad Hajarizadeh, Gregory J Dore
Nephrology (Carlton, Vic.)|June 4, 2008
Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patientsShahnaz Sali, Seyed M Alavian, Behzad Hajarizadeh
The Medical Journal of Australia|April 20, 2020
Hepatitis C elimination in Australia: progress and challengesMarianne Martinello, Behzad Hajarizadeh, Gregory J Dore
Nature Reviews. Gastroenterology & Hepatology|July 3, 2013
Epidemiology and natural history of HCV infectionBehzad Hajarizadeh, Jason Grebely, Gregory J Dore
Australian and New Zealand Journal of Public Health|October 5, 2013
Challenges in managing patients in Australia with chronic hepatitis B: the General Practitioners' perspectiveJack Wallace, Behzad Hajarizadeh, Jacqui Richmond, et al.
BMC Endocrine Disorders|November 24, 2004
Prevalence and determinants of diabetes mellitus among Iranian patients with chronic liver diseaseSeyed M Alavian, Behzad Hajarizadeh, Fariborz Nematizadeh, et al.
Pageof 16